The Subject Expert Committee of the Central Drugs Standard Control Organisation did not approve Serum Institute of India’s..
Novavax COVID-19 vaccine
Vaccine candidate against COVID-19
The Novavax COVID-19 vaccine, codenamed NVX-CoV2373, is a COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI), that is undergoing trials in India under the brand name Covovax. It requires two doses and is stable at 2 to 8 °C refrigerated temperatures.